MIGRAVENT
Natural health product licensed in Canada
- Licence holder
- Vita Sciences, LLC
- NPN or DIN-HM
- 80067712
- Status
- Active licence
- Licence date
- 15 March 2016
- Revision date
- Not provided
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Procédé de fermentation à l'aide de bactéries et/ou de levures | 50 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : bactéries, levures | 50 mg | Not calculated |
| Magnésium Source : Oxyde de magnésium | 57.3 mg | 171,900 µg |
| Magnésium Source : Citrate de magnésium | 57.3 mg | 171,900 µg |
| Riboflavine Source : Riboflavine | 133 mg | 399,000 µg |
| Petasites hybridus Source : Rhizome (standardized extract) Potency : 15 % petasins | 50 mg | Not calculated |
Non-medicinal ingredients
Chlorophyllin copper complex sodium, Gélatine, Eau purifiée, Curcuma, Glycérine, Isolat de protein de pois, Lycopène, Huile de carthame, Isomalt, gomme acacia, Maltodextrine, Lécithine, Cire d'abeille blanc, Sucrose Fatty Acid esters, Acide ascorbique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Gélule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce the frequency of migraine headaches when taken preventatively/as a prophylactic. Helps to reduce severity of migraine attacks when taken as a prophylactic. Preventative treatment to reduce the frequency of migraine headaches and associated symptoms. Help(s) prevent migraine headaches. Help(s) reduce the severity and/or frequency of migraine headaches and associated symptoms such as nausea and vomiting, when taken as a prophylactic. Helps reduce the frequency and intensity of migraine headaches, as well as associated symptoms. A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps in tissue formation. Helps in the development and maintenance of bones and teeth. Helps to maintain proper muscle function. Helps to maintain and/or support cardiovascular health. An antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80067712
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.